baber/WOPTO huggingface dataset:
Patent NZ-333479-A (NZ)
Title: aqueous base suspension concentrate containing at least one ionophore antibiotic
Inventor: MOORE DEREK GEORGE
IPC: A61K31/625
Filed: 1995-07-14
Abstract: The aqueous base suspension concentrate comprises at least one ionophore antibiotic in an aqueous system containing: a) a polyglycoside as a wetting and/or surfactant agent; b) at least one antifreeze agent in which the at least one ionophore antibiotic is no more than sparingly soluble; c) a suspension agent excluding xanthan gum; d) optional ingredients chosen from an antifoam agent or system, a de-bittering agent, a preservative and a pH buffering system and e)  water. The concentrate is capable of aqueous dilution is desired and (with or without aqueous dilution) capable of being orally administered to an animal such as by drenching.
Patent NZ-334946-A (NZ)
Title: Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5%w/w
Inventor: COOLBEAR KAY PATRICIA
IPC: A23J1/20
Filed: 1997-10-01
Abstract: The process for purifying a glycomacropeptide (GMP) comprises: a) contacting a GMP containing feedstock with a first anion exchanger under conditions to absorb the GMP; b) eluting the absorbed GMP from the anion exchanger and removing the impurities from the GMP containing eluate by either (i) contacting the GMP containing eluate with a cation exchanger in conditions under which the impurities in the eluate are absorbed onto the cation exchanger or (ii) precipitating the impurities in the GMP containing eluate using conditions by means of which the GMP remains in solution or (iii) contacting the GMP containing eluate with a second anion exchanger in conditions under which the impurities in the eluate are absorbed onto the anion exchanger and c) recovering the GMP from whichever one or more of steps i) to iii) was used. The GMP has an amino acid composition containing not greater than 0.5%(w/w) phenylalanine (Phe).
Patent NZ-336074-A (NZ)
Title: Solid or semi-solid formulation for placement at a precise deposition site formulated for local effect
Inventor: CHERIF-CHEIKH ROLAND
IPC: A61K9/70
Filed: 1997-12-02
Abstract: A solid or semi-solid formulation contains a limited dose of at least one active principle for a treatment in a targeted zone of the body and is intended for placement in a precise site of deposition in a body such that it is able to persist for a certain period in the site.  The limited dose is an amount selected to be effective locally and not systemically.  The formulation has a form making it capable of being placed by a device comprising a hollow guide means for packaging of the solid or semi-solid form, means for positioning allowing these means of packaging to be led into the site of deposition, piston means in the guide means for injection or insertion at this depot site and means of withdrawal after injection or insertion and a part left outside with means of operation of the functions of the device.
Patent NZ-503128-A (NZ)
Title: Membrane virus host range mutations and their uses as vaccine substrates especially in viral diseases spread by mosquito
Inventor: HERNANDEZ RACQUEL
IPC: C12N7/04
Filed: 1998-09-18
Abstract: The vaccines and methods of the present invention are based on deletion mutations in the protein transmembrane domains of membrane-enveloped viruses. The strategy for production of these mutations is based on the fact that unlike mammalian cell membranes, the membranes of insect cells contain no cholesterol; thus are thinner than mammalian membranes. Many membrane-coated viruses have membrane glycoproteins on their surface that are responsible for identifying and infecting target cells. These membrane glycoproteins have hydrophobic membrane-spanning domains that anchor the proteins in the membrane bilayer. The membrane-spanning domains of these transmembrane proteins must be long enough to reach from one side of the bilayer to the other in order to hold the proteins in the membrane. Provided is a vaccine, a method of producing this vaccine, and the use of this viral vaccine, based on the differences between membranes of viruses replicated in invertebrates and membranes of viruses replicated in vertebrates.
Patent NZ-504026-A (NZ)
Title: Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
Inventor: GRINNELL BRIAN WILLIAM
IPC: A61P31/04
Filed: 1998-10-14
Abstract: Use of activated protein C in the manufacture of a medicament for the treatment of an acquired hypercoagulable state or acquired protein C deficiency by continuous infusion for about 24 to about 144 hours a dosage of about 20 mu g/kg/hr to about 50 mu g/kg/hr of human activated protein C.
Patent NZ-508402-A (NZ)
Title: Dry powder deposition apparatus for electrostatic deposition of a pharmaceutical powder
Inventor: ROSATI DOMINIC STEPHEN
IPC: A61K9/70
Filed: 1999-06-08
Abstract: A dry powder deposition apparatus for depositing powder on a substrate comprises a deposition means for electrostatically depositing the powder at discrete locations on the substrate and an optical measurement device for nondestructively measuring the amount of powder deposited on the substrate. The powder comprises a pharmaceutically- or biologically active ingredient on a substrate and wherein. The deposition means comprises an electrostatic chuck wherein the electrostatic chuck has at least one collection zone. The collection zone is operable in conjunction with a bias source to generate a powder-attracting electrostatic field and the substrate is detachably engaged to the electrostatic chuck and overlies the collection zone.
Patent NZ-508642-A (NZ)
Title: Cyclic boroproline compounds
Inventor: WALLNER BARBARA P
IPC: C07F5/02
Filed: 1999-05-14
Abstract: Pharmaceutical compositions comprising a cyclic boroProline compound of formula I, wherein: X1 and X2 is independently a hydroxyl group or a group capable of being hydrolysed to a hydroxyl group in aqueous solution at physiological pH, X is a side chain of an amino acid or a peptide which mimics the site of a substrate recognised by a post prolyl cleaving enzyme. The pharmaceutical compositions are sued in the manufacture of medicaments for stimulating activation or proliferation of human lymphocytes or hematopoietic cells.
Patent NZ-508839-A (NZ)
Title: FKBP-type immunophilin inhibitors
Inventor: MAGUIRE ROBERT JOHN
IPC: A61P43/00
Filed: 1999-07-01
Abstract: A compound of formula (I), substituents defined within; and a process for its preparation, whereby a compound of formula (II) is reacted with a compound of formula (III).  Compounds of formula (I) have an affinity for and act as inhibitors of FKBP-type immunophilins  (particularly FKBP-12 and FKBP-52), without inhibiting the protein phosphatase calcineurin thus lacking any significant immunosuppressive activity.
Patent NZ-518797-A (NZ)
Title: Preparation of particulate compositions by wet milling a compound as a dispersion in a mill having at least one mill chamber, the chamber being lined with an abrasion- reistant polymeric material
Inventor: DUMPLETON DAVID ROBERT
IPC: A61K9/14
Filed: 1998-12-14
Abstract: A process for preparing a particulate composition, comprising wet milling a compound as a dispersion in a mill having at least one mill chamber. The chamber is lined with or constructed from an abrasion-resistant polymer material. The compound to be milled is a compound of formula (I) or formula (II).
Patent NZ-519036-A (NZ)
Title: Methods of blocking an ethylene response in plants using cyclopropene derivatives
Inventor: SISLER EDWARD C
IPC: A01N37/34
Filed: 2000-11-22
Abstract: A method of inhibiting an ethylene response in a plant involving applying to the plant an effective ethylene response-inhibiting amount of a compound of Formula I, where n is a number from 1 to 4, and each R is independently a saturated or unsaturated, linear or branched-chain, unsubstituted or substituted, C6-C20 alkyl, alkenyl, or alkynyl. It also involves a method of applying of a compound of Formula II to achieve an effective response inhibiting ethylene as described above. In Formula II, n is a number from 1 to 4, and each R is independently a saturated or unsaturated, linear or branched-chain, unsubstituted or substituted , C5 alkyl, alkenyl or alkynyl. Also it is a method using either Formula I or II to inhibit the ripening of picked fruit and vegetables, prolonging life of cut flowers, and causing abscission inhibition in a plant.
Patent NZ-520454-A (NZ)
Title: Fishing line retrieval unit consisting of aluminium alloy drum for winching nylon around
Inventor: SMITH THOMAS KENWORTHY
IPC: A01K73/06
Filed: 2002-08-21
Abstract: It is usual practice to use lightweight plastic or metal drums, acting as a winch, to bring a long line hack to shore. The disadvantage of this is the possibility of the drum bursting under pressure from the nylon lines when the line is wound too tightly. The winch as disclosed uses a marine grade aluminium alloy material for its drum (1) to avoid damage to the drum. As added support, the drum is mounted onto a frame using two alloy brackets (2). The winch is driven by an axle (3) connected to a 12V battery (10) powered motor (8). For manual winding, the axle can be slid away from the motor by removing the locking pin (4). The removal of the pin also allows for the entire axle to be removed and hence removal or replacement of drum.
Patent NZ-524063-A (NZ)
Title: Integrated spark and switch unit for combustion fastener driving tool
Inventor: SHKOLNIKOV YURY
IPC: F02P11/04
Filed: 2003-02-07
Abstract: A combustion-powered tool (10) having a workpiece contacting element (22) movable relative to the tool as the tool is depressed prior to firing includes a spark unit (30) having a high voltage spark supply (36) for providing an ignition spark, a printed circuit board (32) having a first portion (34) configured for receiving and being electrically connected to the high voltage spark supply (36), and a second portion (38) configured for receiving and being electrically connected to both an actuator switch (40) and a trigger switch (42), the switches and the spark supply (36) being electrically connected so that to enable firing, the workpiece (22) contact element actuates the actuator switch (40), which then enables activation of the trigger switch (42). A unitary actuator has a fixed end, a movable end engageable by movement of the workpiece contact element (22) and a middle portion for engaging the actuator switch (40) upon movement of the movable end caused by depression of the tool against a workpiece (22).
Patent NZ-524545-A (NZ)
Title: Plastic container having a carbon-treated internal surface for non-carbonated food products
Inventor: SLAT WILLIAM A
IPC: B29C49/00
Filed: 2001-09-26
Abstract: A container (10), desirably blow molded or extrusion molded, said container having barrier properties and including an upper wall portion (12) having an opening (13), an intermediate sidewall portion (14) positioned beneath the upper wall portion (12), and a base portion (16) positioned beneath the intermediate sidewall portion (14) to support the container. The container (10) includes a molded first layer (22) having an inner surface an outer surface formed from high density polyethylene, and a carbon coating (26) formed on the inner surface of the first layer and adhered thereto and substantially coextensive with the first layer, wherein said carbon coating (26) has a thickness of less than about 10 microns.
Patent NZ-525596-A (NZ)
Title: Sealed container
Inventor: TSAUR GARRY
IPC: B65D65/30
Filed: 2003-04-29
Abstract: A sealed container for liquids such as perfumes has a sealed elongate housing 1 with one or more opening means 2 (e.g. scores on the sealed container) and a divider 6 such as an open-ended tube within the housing around which the fluid 4 can flow freely. When the container is opened, the fluid is allowed to flow out easily, as the dividers negate the hindering effects of capillary action and atmospheric pressure. Cotton balls 5 can be attached over the opening means if desired to receive the liquid once the container has been opened.
Patent NZ-527157-A (NZ)
Title: Compositions for delivering bisphosphonates
Inventor: BOYD MARIA A P
IPC: C07C235/64
Filed: 2002-03-01
Abstract: Disclosed are compositions comprising at least one of the delivery agents described herein, and at least one bisphosphonate. The compositions are used to facilitate the delivery of bisphosphonate to selected biological systems and increase or improve the bioavailability of bisphosphonate compared to administration without the delivery agent compound.
Patent NZ-527994-A (NZ)
Title: Carbamate compounds for use in the treatment of pain
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61K31/27
Filed: 2002-02-21
Abstract: Use of a carbamate compound, selected from Formula (I) or Formula (II), is described to be for the preparation of a medicament for the treatment of pain. Phenyl is substituted at X with one to five halogen atoms selected from fluorine, chlorine, bromine and iodine; and R1, R2, R3, R4, R5 and R6 are independently selected from hydrogen and C1-C4 alkyl, which is optionally substituted with phenyl (wherein phenyl is also optionally substituted). Disclosed is the use of an enantiomer selected from Formula (I) or (II), or an enantiomeric mixture wherein one enantiomer selected from Formula (I) or (II) predominates. The use is described to be for the preparation of a medicament for the treatment of pain, such as acute and chromic pain that is centrally or peripherally mediated, caused by structural tissue injury, trauma or by progressive disease.
Patent NZ-535352-A (NZ)
Title: Apparatus and method for lifting aerial cables
Inventor: SHEPHERD KEIRON
IPC: H02G1/02
Filed: 2003-03-03
Abstract: A portable telescopic lifting apparatus (1) for lifting aerial cables (53). The apparatus ( 1 ) comprises a tubular housing ( 2 ), first and second telescopic members ( 3, 4 ) extendible from and retractable into the housing ( 2 ), a drive ( 5, 60 ) for extending and retracting the telescopic members ( 3, 4 ), and a cable-engaging member ( 51 ) attached to the second telescopic member ( 4 ) for lifting one or more aerial cables ( 53 ). The drive (5, 60) comprises a chain lever block (5) and a pulley arrangement (60). In use, the apparatus ( 1 ) is positioned below one or more aerial cables ( 53 ), the chain lever block ( 5 ) is used to raise the first telescopic member ( 3 ), the first telescopic member ( 3 ) extends from within the housing ( 2 ), the second telescopic member ( 4 ) extends from within the first telescopic member ( 3 ), and cable-engaging member ( 51 ) raises the cable/s ( 53 ).
Patent NZ-536209-A (NZ)
Title: Reduced keyboard system that emulates qwerty-type mapping and typing
Inventor: NG EDWIN
IPC: G06F3/01
Filed: 2003-03-07
Abstract: A reduced keyboard system (100), with a reduced number of keys (13, 15, 23, 25, 102, 104, 106, 108, 110, 112), retains the typing map of the conventional QWERTY or QWERTY-type keyboard by employing an intuitive and learning database engine. A plurality of letters, numerals, symbols and functions are assigned to a set of data keys, buttons or data inputs (multi-character keys). The arrangement of the multi-character keys together with the character assignments to the individual multi-character keys allows a user to use the same typing map, as when typing on a conventional QWERTY or QWERTY-type keyboard, be it visual mapping (i.e. physical location of keys) or finger mapping (i.e. touch typing for typist). The keys are not chordal, so, at the beginning of a word, when a key receives a single key press one of the characters associated with the key is identified and displayed, which one depending on, say, a frequency table of the associated keys held in the database. The first character can be corrected by pressing the cycle key to go through the other characters associated with the key (rather than the same key again). As the word is built however with further key presses, the consequent character generated from each key press from the limited number of characters associated with the key, is extracted from the database in accordance with the sequence of keystrokes so far made.
Patent NZ-539758-A (NZ)
Title: Method for forming a security stopper-capsule and applying it to containers with a threaded mouth, and the stopper-capsule obtained thereby
Inventor: PIERO MACCHI FRANCESCO
IPC: B65D41/62
Filed: 2003-10-15
Abstract: The method enables a closure and security device (22) comprising a screw stopper (l0A) and a security capsule (16A) to be formed and applied to a container (20) provided with an externally threaded circular mouth. The method consists of: connecting to a screw stopper (10), or to a stopper destined to become a screw stopper once applied to the container (20), a capsule forming foil (12) in such a .manner as to provide the stopper (10) with a skirt (16) projecting by a determined portion from the free edge of the stopper (10), to obtain -a-stopper-skirt combination,(18; 18A; 18B); applying the stopper- skirt combination (18; 18A; 18B) to the mouth of the relative container (20); and making the skirt (16) rigid with the container (20) by known capsule techniques, depending on the type of foil used, so as to obtain a stopper-capsule (22). The closure and security device (22) comprises a screw stopper (10A), and a capsule (16A) which is rigid both with the screw stopper (10A) and with the adjacent part of the outer surface of the container (20). The capsule (16A) comprises means (24) which enable it to be torn as a result of or prior to the unscrewing of the screw stopper).
Patent NZ-541039-A (NZ)
Title: Gas capsules and method of filling them
Inventor: BARRETT MICHAEL ANTHONY
IPC: F17C13/06
Filed: 2004-01-07
Abstract: A gas capsule comprises a hollow body portion (1) and a cap (2) including a stem (3) providing a filling orifice (3A). Prior to assembly of the body portion (1) and the cap (2) a stopper member (4) is inserted loosely within the capsule. During filling of the capsule with gas, the stopper member (4) is located within the body of the capsule and, prior to release of the gas pressure at the orifice (3A) of the capsule, the stopper member is moved to obstruct the path of gas from the capsule, for example by inverting the capsule so that the stopper member falls under gravity into a position between the body of the capsule (1) and the filling orifice (3A). The gas pressure is then released so that the stopper member (4) is forced into the stem (3) under the pressure of the gas to form a gas tight seal closing the orifice (3A). The orifice (3A) may then be welded to form a permanent closure.
Patent NZ-546047-A (NZ)
Title: Roof ventilator with damper flaps pivotally mounted for movement in unison under the effect of fan-induced air flow
Inventor: WATSON STEPHEN WILLIAM
Filed: 2006-03-21
Abstract: Roof ventilator flaps 2 are pivoted to rotate about a horizontal axis under the effect of fan-induced airflow, with the flaps returning to a closed position when the airflow ceases at least under normal operating conditions. The flaps are mechanically linked so as to pivot in unison when moving between their closed and open positions.
Patent NZ-547447-A (NZ)
Title: Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders
Inventor: ZELDIS JEROME B
IPC: A61K31/7048
Filed: 2004-11-04
Abstract: Disclosed is the use of a compound of formula (I), (II) or (III), wherein the substituents are as defined in the specification, and the compounds 3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydroisoindol-2-yl)-propionamide and cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide, or pharmaceutically acceptable salts, solvates or stereoisomers thereof, in the manufacture of a pharmaceutical composition for treating, preventing or managing an asbestos-related disease or disorder such as mesothelioma, asbestosis, pleural effusion, pleural plaque, pleural calcification, diffuse pleural thickening, round atelectasis, or bronchogenic carcinoma.
Patent NZ-549784-A (NZ)
Title: Inhibitors of CTGF the manufacture of a medicament for the treatment of diabetic nephropathy
Inventor: FLYVBJERG ALLAN
IPC: A61K39/395
Filed: 2005-02-11
Abstract: Disclosed are agents that inhibit CTGF in the manufacture of a medicament for the treatment of specific early stage aspects and late stage aspects of diabetic nephropathy. The use of these agents are also disclosed for the manufacture of a medicament for treating various physiological features associated with early stage and with late stage diabetic nephropathy.
Patent NZ-561574-A (NZ)
Title: Anti-inflammatory modalities for use against pain, oedema, and erythema (benzotetrahydropyrans, benzopyran derivatives, isoflavonoid derivatives)
Inventor: WALKER CATHERINE
IPC: A61K31/353
Filed: 2006-03-24
Abstract: Disclosed is the use of a compound of formula (I), or a salt thereof, wherein R1 and R2 are each hydroxy, C1-6alkoxy, or C1-6acyloxy, R3 is hydroxy, C1-6alkoxy, C1-6alkyl, or halo, and X is either =O or hydrogen and hydroxy, for treating pain, oedema, or erythema associated with an inflammatory disease.
Patent NZ-561676-A (NZ)
Title: Methods and device for transmitting, enclosing and analysing fluid samples
Inventor: OVISO DOMINADOR FORTALEZA
Filed: 2005-03-16
Abstract: A microfluidic device for analysing a fluid sample, comrprising at least one sample transmission channel 1, at least one multi-functional channel 3 and at least one reactor module 11 fluidly connecting the sample transmission channel 1 to the multi-functional channel 3. The reactor module 11 comprises at least one reaction chamber 15 having at least one inlet in fluid communication with the at least one sample transmission channel 1, and at least one fluid isolation chamber 23, the fluid isolation chamber 23 being in fluid communication with at least one outlet 18/20 of the at least one reaction chamber 15, wherein the fluid isolation chamber 23 isolates the fluid sample from the least one multi-functional channel 3.
Patent NZ-563092-A (NZ)
Title: Mono-lysine salts of azole compounds
Inventor: GAO QI
IPC: A61K31/427
Filed: 2006-05-01
Abstract: Disclosed is a mono-lysine salt of a compound, of formula I or a solvate thereof, wherein the substituents are as defined in the specification. Also disclosed is the use of the salt to treat a fungal infection, and a process for preparing the salt.
Patent NZ-567685-A (NZ)
Title: A Factor IX formulation for injection comprising sodium chloride
Inventor: WEBB CHANDRA A
IPC: A61K47/18
Filed: 2006-10-27
Abstract: Disclosed is a method for preparing a Factor IX formulation for intravenous injection, the method comprising adding an about 25-150 mM sodium chloride solution to a lyophilized Factor IX formulation, thereby resulting in a formulation prepared for intravenous injection, wherein the prepared formulation has an osmolarity that is from about 220-600 mOsm/L, and wherein the prepared formulation has a sufficient ionic strength to prevent erythrocyte agglutination upon intravenous injection.
Patent NZ-571719-A (NZ)
Title: Gutter bracket
Inventor: BUSHELL WALTER LESLIE
IPC: E04D13/072
Filed: 2008-10-02
Abstract: A gutter bracket 10 comprising a rear plate member 20, an upper shelf 22, a lower shelf 23, spaced from the upper shelf 22, each shelf 22 23 extending forwardly of the plate 20 and having an interior strip surface 24 adapted to abut a rear wall of a gutter, a bridge 26 extending from the upper shelf 22, and a support arm 30 extending from the bridge 26 and adapted to engage a gutter